Non-thermal plasma with metformin synergistically induces cell death via upregulating AMPK to suppress energy metabolism
Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › 21_Publication in refereed journal › peer-review
Author(s)
Related Research Unit(s)
Detail(s)
Original language | English |
---|---|
Article number | 385203 |
Journal / Publication | Journal Physics D: Applied Physics |
Volume | 53 |
Issue number | 38 |
Online published | 1 Jul 2020 |
Publication status | Published - 16 Sep 2020 |
Link(s)
Abstract
Non-thermal plasma (NTP) has a selective killing effect on a variety of cancer cells in vivo and in vitro, and is considered a potential tumor therapy. In this study, we found that metformin, which has shown promising antitumor effects in previous studies, with NTP synergistically increased cell death including apoptosis in colon cancer cell lines via reducing mitochondrial oxidative phosphorylation and intracellular adenosine triphosphate exhausting cellular energy, mediated through activation of AMP-activated protein kinase (AMPK). Reactive oxygen species was revealed to modulate the activation of AMPK after NTP exposure. Considering the safety and wide clinical use of metformin, the combination of metformin and NTP showed great potential in cancer therapy.
Research Area(s)
- non-thermal plasma, metformin, AMP-activated protein kinase, energy metabolism, ACTIVATED PROTEIN-KINASE, CANCER PREVENTION, COMPLEX 1, APOPTOSIS, ROS, INDUCTION
Citation Format(s)
Non-thermal plasma with metformin synergistically induces cell death via upregulating AMPK to suppress energy metabolism. / Cui, Shujun; Chen, Guodong; Yu, K. N. et al.
In: Journal Physics D: Applied Physics, Vol. 53, No. 38, 385203, 16.09.2020.Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › 21_Publication in refereed journal › peer-review